Protalix BioTherapeutics Reports Second Quarter 2020 Financial Results and Provides Business Update

PRNewswire/ — Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production …

( read original story …)